Rfg Advisory, LLC Eli Lilly & CO Transaction History

Rfg Advisory, LLC

$3.42 Billion
Q4 2024

A detailed history of Rfg Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rfg Advisory, LLC holds 10,212 shares of LLY stock, worth $8.88 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

10,212

Previous 9,006 13.39%

Holding current value

$8.88 Million

Previous $7.98 Million 1.19%

% of portfolio

0.23%

Previous 0.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$727.2 - $932.06 $877,003 - $1.12 Million	1,206 Added 13.39%	10,212 $7.88 Million
Q3 2024 Oct 16, 2024	BUY	$772.14 - $960.02 $490,308 - $609,612	635 Added 7.59%	9,006 $7.98 Million
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $1.36 Million - $1.7 Million	1,871 Added 28.78%	8,371 $7.58 Million
Q1 2024 Apr 11, 2024	BUY	$592.2 - $792.28 $116,663 - $156,079	197 Added 3.13%	6,500 $5.06 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $150,729 - $177,690	287 Added 4.77%	6,303 $3.67 Million
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $624,229 - $860,594	1,436 Added 31.35%	6,016 $3.23 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $109,781 - $146,790	313 Added 7.34%	4,580 $2.15 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $15,220 - $17,876	49 Added 1.16%	4,267 $1.47 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $291,324 - $339,451	-906 Reduced 17.68%	4,218 $1.54 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $162,767 - $185,490	549 Added 12.0%	5,124 $1.88 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $64,665 - $75,926	232 Added 5.34%	4,575 $1.38 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $62,662 - $77,873	267 Added 6.55%	4,343 $1.24 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $134,010 - $166,307	596 Added 17.13%	4,076 $1.13 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $15,290 - $18,816	69 Added 2.02%	3,480 $804,000
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $66,984 - $86,643	-371 Reduced 9.81%	3,411 $783,000
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $22,840 - $29,568	-139 Reduced 3.55%	3,782 $707,000
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $6,262 - $8,286	-48 Reduced 1.21%	3,921 $653,000
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $69,893 - $80,844	478 Added 13.69%	3,969 $587,000
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $46,109 - $55,492	338 Added 10.72%	3,491 $573,000
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $15,952 - $19,744	-134 Reduced 4.08%	3,153 $437,000
Q4 2019 Jan 22, 2020	SELL	$106.92 - $132.43 $45,975 - $56,944	-430 Reduced 11.57%	3,287 $432,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $67,491 - $73,413	632 Added 20.49%	3,717 $416,000
Q2 2019 Aug 23, 2019	BUY	$110.79 - $129.32 $341,787 - $398,952	3,085 New	3,085 $340,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $294,701 - $343,991	-2,660 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$111.31 - $131.02 $38,735 - $45,594	348 Added 15.05%	2,660 $344,000
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $88,214 - $98,827	-833 Reduced 26.49%	2,312 $268,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $270,029 - $337,489	3,145 New	3,145 $337,000

Others Institutions Holding LLY

# of Institutions

4,282

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $826B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Account